On 1 September, TEN4CARE (Tendon Engineering for Comprehensive Advanced Rehabilitation and Enhancement) officially gets underway. This ambitious innovation project, funded by the European Union under the Horizon Europe programme (grant agreement number 101178590), will take a crucial step towards transforming the treatment of tendon injuries.
TEN4CARE’s main objective is to develop innovative, minimally invasive and personalised solutions for tendon injuries. This will be achieved through the design of a medical device based on advanced biomaterials with shape memory and 4D hydrogels sensitive to electromagnetic fields, loaded with an anti-inflammatory drug and magnetic nanoparticles. Our goal is to significantly improve tendon repair, reduce recurrence rates and promote tissue regeneration, minimising the complications associated with current surgical approaches.
This 48-month project brings together a multidisciplinary consortium of 16 partners from 7 European countries, including Spain, Italy, the United Kingdom, Portugal, Belgium, Germany and Ireland. The UNIVERSITA DEGLI STUDI DI PAVIA (UNIPV) is the coordinator of this initiative. We are immensely proud to have received total funding of €7,929,471.47 from the European Union, which validates the relevance and transformative potential of our proposal.
Biokeralty, with funding of €597,500, plays a central and multifaceted role in the TEN4CARE project. It leads the management of communication, dissemination and stakeholder engagement (WP11 and WP12), being responsible for the creation of strategic plans, the project website and social media presence to maximise public impact and collaboration with diverse audiences.
Furthermore, in WP10, ‘Exploitation and pathways to commercialisation’, Biokeralty is an active partner in all tasks, contributing significantly to the development of the regulatory strategy, life cycle sustainability assessment, market analysis and business model definition, intellectual property protection, and cost-benefit analysis with pricing recommendations.
Together with the University of Pavia (UNIPV), BK co-leads crucial aspects of project coordination and management (WP13, WP14 and WP15), ensuring governance, scientific, technical and innovation management, as well as legal, privacy and ethical compliance.
As part of our first milestones, the Kick-off Meeting will be held in Pavia on 2 and 3 October. Our official website will be available shortly, serving as a comprehensive hub for following our progress and accessing detailed information about the project.
We invite you to follow us on LinkedIn and join us on this exciting adventure. Together, we will advance tissue engineering to improve the lives of millions of people with tendinopathies!
